Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Schuetz

Showing results (11-20 of 502) with videos related to

Pageof 51
Sort By:
Clinical Chemistry and Laboratory Medicine|March 6, 2015
"Personalized" sepsis care with the help of specific biomarker levels on admission and during follow up: are we there yet?Philipp Schuetz
American Journal of Respiratory and Critical Care Medicine|December 5, 2019
Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired PneumoniaPhilipp Schuetz
Lancet (London, England)|September 16, 2023
EFFORT Protein trial: questions remainPhilipp Schuetz
Praxis|May 25, 2022
Philipp Schuetz
Chest|June 9, 2024
More EFFORT Is Needed to Understand How to Individualize Optimal Protein Targets to the Needs of Patients Who Are Critically IllPhilipp Schuetz
The American Journal of Clinical Nutrition|June 4, 2025
A key step toward gaining a deeper understanding of individual responses to protein supplementationPhilipp Schuetz
Clinical Chemistry and Laboratory Medicine|November 1, 2022
How to best use procalcitonin to diagnose infections and manage antibiotic treatmentPhilipp Schuetz
Diagnosis (Berlin, Germany)|March 16, 2018
Can biomarkers help us to better diagnose and manage sepsis?Philipp Schuetz, Mario Plebani
Lancet (London, England)|July 17, 2017
Procalcitonin-guided antibiotic stewardship from newborns to centennialsPhilipp Schuetz, Beat Mueller
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 4, 2008
Efficient modularity optimization by multistep greedy algorithm and vertex mover refinementPhilipp Schuetz, Amedeo Caflisch
Pageof 51

Showing results (11-20 of 502) with videos related to

Sort By:
Pageof 51
Clinical Chemistry and Laboratory Medicine|March 6, 2015
"Personalized" sepsis care with the help of specific biomarker levels on admission and during follow up: are we there yet?Philipp Schuetz
American Journal of Respiratory and Critical Care Medicine|December 5, 2019
Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired PneumoniaPhilipp Schuetz
Lancet (London, England)|September 16, 2023
EFFORT Protein trial: questions remainPhilipp Schuetz
Praxis|May 25, 2022
Philipp Schuetz
Chest|June 9, 2024
More EFFORT Is Needed to Understand How to Individualize Optimal Protein Targets to the Needs of Patients Who Are Critically IllPhilipp Schuetz
The American Journal of Clinical Nutrition|June 4, 2025
A key step toward gaining a deeper understanding of individual responses to protein supplementationPhilipp Schuetz
Clinical Chemistry and Laboratory Medicine|November 1, 2022
How to best use procalcitonin to diagnose infections and manage antibiotic treatmentPhilipp Schuetz
Diagnosis (Berlin, Germany)|March 16, 2018
Can biomarkers help us to better diagnose and manage sepsis?Philipp Schuetz, Mario Plebani
Lancet (London, England)|July 17, 2017
Procalcitonin-guided antibiotic stewardship from newborns to centennialsPhilipp Schuetz, Beat Mueller
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 4, 2008
Efficient modularity optimization by multistep greedy algorithm and vertex mover refinementPhilipp Schuetz, Amedeo Caflisch
Pageof 51